Lv4
780 积分 2023-04-30 加入
PARP Inhibitors for Breast Cancer Treatment
1个月前
已完结
Forget lung, breast or prostate cancer: why tumour naming needs to change
3个月前
已完结
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
3个月前
已完结
Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
4个月前
已完结
XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer
4个月前
已完结
Mammalian IRE1α dynamically and functionally coalesces with stress granules
4个月前
已完结
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
5个月前
已完结
A Framework of Effective Science Explanation Videos Informed by Criteria for Instructional Explanations
6个月前
已完结
Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens
11个月前
已完结
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China
1年前
已完结
皖公网安备34019202002308
